Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

PURPOSE: Beginning in July of 2018, the FDA issued a voluntary recall regarding the presence of a contaminant found in the manufacturing of valsartan. What would ensue has become a largely unprecedented sequence of alarming events since the FDA began reporting public recalls, withdrawals and safety...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Drugs Ther
Main Authors: Gillette, Michael, Taylor, Addison, Butulija, Djenita, Kadiyala, Himabindu, Jneid, Hani
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2020
Fag:
Editorial
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171054/
https://ncbi.nlm.nih.gov/pubmed/32318933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-06976-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker